THE RISKS OF CONTINUING TRASTUZUMAB TREATMENT IN HER-2 POSITIVE BREAST CANCER AFTER THE DEVELOPMENT OF ASYMPTOMATIC LEFT VENTRICULAR DYSFUNCTION ArticleJoseph M.MD., Shavarova E.K., Ezhova N.E., Abdulloev D.I., Kazakova O.V., Shavarov A.A., Khoruzhaya S.S., Pokataev I.A., Galkin V.N., Kobalava Z.D.EUROPEAN JOURNAL OF HEART FAILURE. Том 26. 2024. С. 579-579
